How to Spot Misleading Telehealth Ads for Mental Health Care
Social media ads for telehealth can make mental health diagnosis and treatment seem fast and simple. Some companies have drawn penalties for prescribing restricted psychiatric medications without enough oversight. The article lists warning signs to help people assess these platforms and their promises.
When pandemic-era rules temporarily eased, remote clinicians could prescribe certain restricted psychiatric medicines while in-person access was scarce. This helped open a sizable market for therapy startups, some later accused of insufficient oversight, hurried diagnoses, and questionable prescribing.
Social feeds often frame depression, anxiety, or ADHD as problems solvable through quick quizzes and subscription care. Influencers and celebrities endorse these services, and certain firms have drawn penalties or arrests over improper prescribing. Other reported worries include low therapist pay, patient-data sales, and recorded sessions used to train AI.
People who turn to social media for mental health guidance could be swayed by polished ads promising fast relief, potentially receiving unsuitable diagnoses or medicines. Those already facing barriers to care may be especially vulnerable. Wider effects may include privacy concerns, strained trust in legitimate telehealth, and greater scrutiny of platforms and advertisers. Clinicians and responsible services could also bear reputational fallout as public awareness of misleading practices grows.